Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HCA Healthcare, Inc.HCA · Entity 2929 | Director · CEO | February 10, 2026 | February 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HCA Healthcare, Inc.
Report date February 10, 2026 · Filed February 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 64,842 |
Ending reported balance
After 2026-02-10 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-02-10 · Grant · Acquired 54,934 · Balance 86,165 F1: On January 30, 2023, the reporting person was granted 27,467 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2023-2025. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2023-2025 earnings per share, the number of performance share units that vested equaled 200% of the units granted. Row 2 · 2026-02-10 · Tax withholding · Disposed 21,323 · Balance 64,842 |
| Common StockSEC Table I · non-derivative | IndirectBy HD Trust | 16,024 |
Reported balance
Holding disclosure · report date 2026-02-10 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 16,024 |
| Common StockSEC Table I · non-derivative | IndirectBy 2023 GST Trust | 16,731 |
Reported balance
Holding disclosure · report date 2026-02-10 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 16,731 |
| Common StockSEC Table I · non-derivative | IndirectBy 2023 Trust | 93,088 |
Reported balance
Holding disclosure · report date 2026-02-10 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 93,088 |
| Common StockSEC Table I · non-derivative | IndirectBy 2024 GRAT | 178,289 |
Reported balance
Holding disclosure · report date 2026-02-10 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 178,289 |
| Common StockSEC Table I · non-derivative | IndirectBy 2025 GRAT | 200,000 |
Reported balance
Holding disclosure · report date 2026-02-10 · row 7
Holding and transaction disclosures are not merged.
1 source rowRow 7 · Balance 200,000 |
| Common StockSEC Table I · non-derivative | IndirectBy LP | 813,320 |
Reported balance
Holding disclosure · report date 2026-02-10 · row 8
Holding and transaction disclosures are not merged.
1 source rowRow 8 · Balance 813,320 |
Filing footnotes · ownership attribution and instrument terms
F1: On January 30, 2023, the reporting person was granted 27,467 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2023-2025. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2023-2025 earnings per share, the number of performance share units that vested equaled 200% of the units granted.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 10, 2026 Filed Feb 12, 2026 18:45 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 21,323 | $502.05 | $10,705,212.15 |
DisclosureSEC source: 0001193125-26-049200 · ownership.xml · nonDerivative · entry 2 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,842 Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 18:45 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 54,934 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-049200 · ownership.xml · nonDerivative · entry 1 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,165 F1 · kind: On January 30, 2023, the reporting person was granted 27,467 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2023-2025. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2023-2025 earnings per share, the number of performance share units that vested equaled 200% of the units granted. Read SEC document |
| February 04, 2026 Filed Feb 5, 2026 18:33 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | OtherCommon Stock | 1,045 | $498.35 | $520,775.75 |
DisclosureSEC source: 0001193125-26-039805 · ownership.xml · nonDerivative · entry 9 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By HD Trust Disclosed balance after: 16,024 F8 · kind: Pursuant to a power of substitution, on February 4, 2026, the Reporting Person transferred 1,045 shares of common stock of the Issuer to a trust in exchange for assets of equal value. The transfer was made at a price per share equal to $498.35 (the average of the high and low prices of shares of common stock of the Issuer on February 4, 2026). The transfer did not change the total number of shares of common stock of the Issuer of which the Reporting Person may be deemed to have beneficial ownership. The Reporting Person believes that the transfer of shares to the trust constitutes a change in form of beneficial ownership of such shares, exempted by Rule 16a-13 under the Securities Exchange Act of 1934. Read SEC document |
| February 04, 2026 Filed Feb 5, 2026 18:33 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | OtherCommon Stock | 1,045 | $498.35 | $520,775.75 |
DisclosureSEC source: 0001193125-26-039805 · ownership.xml · nonDerivative · entry 8 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,231 F8 · kind: Pursuant to a power of substitution, on February 4, 2026, the Reporting Person transferred 1,045 shares of common stock of the Issuer to a trust in exchange for assets of equal value. The transfer was made at a price per share equal to $498.35 (the average of the high and low prices of shares of common stock of the Issuer on February 4, 2026). The transfer did not change the total number of shares of common stock of the Issuer of which the Reporting Person may be deemed to have beneficial ownership. The Reporting Person believes that the transfer of shares to the trust constitutes a change in form of beneficial ownership of such shares, exempted by Rule 16a-13 under the Securities Exchange Act of 1934. Read SEC document |
| February 03, 2026 Filed Feb 5, 2026 18:33 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 120 | $497.18 | $59,661.40 |
DisclosureSEC source: 0001193125-26-039805 · ownership.xml · nonDerivative · entry 7 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,276 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $497.10 to $497.38, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 03, 2026 Filed Feb 5, 2026 18:33 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 4,293 | $498.12 | $2,138,442.04 |
DisclosureSEC source: 0001193125-26-039805 · ownership.xml · nonDerivative · entry 6 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,396 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $497.49 to $498.385, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 03, 2026 Filed Feb 5, 2026 18:33 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 5,162 | $498.80 | $2,574,793.73 |
DisclosureSEC source: 0001193125-26-039805 · ownership.xml · nonDerivative · entry 5 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,689 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $498.41 to $499.395, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 03, 2026 Filed Feb 5, 2026 18:33 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 6,189 | $500.02 | $3,094,608.93 |
DisclosureSEC source: 0001193125-26-039805 · ownership.xml · nonDerivative · entry 4 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,851 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $499.47 to $500.425, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 03, 2026 Filed Feb 5, 2026 18:33 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 7,395 | $500.69 | $3,702,626.21 |
DisclosureSEC source: 0001193125-26-039805 · ownership.xml · nonDerivative · entry 3 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,040 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $500.44 to $501.425, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 03, 2026 Filed Feb 5, 2026 18:33 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 5,002 | $502.15 | $2,511,756.80 |
DisclosureSEC source: 0001193125-26-039805 · ownership.xml · nonDerivative · entry 2 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,435 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $501.485 to $502.455, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 03, 2026 Filed Feb 5, 2026 18:33 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 14,716 | $502.95 | $7,401,385.71 |
DisclosureSEC source: 0001193125-26-039805 · ownership.xml · nonDerivative · entry 1 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,437 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $502.49 to $503.485, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 30, 2026 Filed Feb 2, 2026 18:49 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 84,360 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001193125-26-034005 · ownership.xml · derivative · entry 10 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 84,360 shares Expires 2027-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018. Read SEC document |
| January 30, 2026 Filed Feb 2, 2026 18:49 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 41,483 | $488.27 | $20,254,904.41 |
DisclosureSEC source: 0001193125-26-034005 · ownership.xml · nonDerivative · entry 2 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,153 Read SEC document |
| January 30, 2026 Filed Feb 2, 2026 18:49 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 84,360 | $81.96 | $6,914,145.60 |
DisclosureSEC source: 0001193125-26-034005 · ownership.xml · nonDerivative · entry 1 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,636 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 18:49 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 55,846 | $0.00 Strike: $482.53 | $0.00 |
DisclosureSEC source: 0001193125-26-034005 · ownership.xml · derivative · entry 9 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,846 Underlying: Common Stock · 55,846 shares Expires 2036-01-29 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2027. Read SEC document |
| November 14, 2025 Filed Nov 18, 2025 18:23 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 14,830 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-286555 · ownership.xml · nonDerivative · entry 1 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,276 Read SEC document |
| October 31, 2025 Filed Nov 4, 2025 18:16 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 58,050 | $0.00 Strike: $69.58 | $0.00 |
DisclosureSEC source: 0001193125-25-265148 · ownership.xml · derivative · entry 9 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 58,050 shares Expires 2026-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on January 29, 2017. Read SEC document |
| October 31, 2025 Filed Nov 4, 2025 18:16 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 28,173 | $459.68 | $12,950,564.64 |
DisclosureSEC source: 0001193125-25-265148 · ownership.xml · nonDerivative · entry 2 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,106 Read SEC document |
| October 31, 2025 Filed Nov 4, 2025 18:16 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 58,050 | $69.58 | $4,039,119.00 |
DisclosureSEC source: 0001193125-25-265148 · ownership.xml · nonDerivative · entry 1 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,279 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2025 Filed May 15, 2025 17:56 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 90,076 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-072916 · ownership.xml · nonDerivative · entry 2 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By 2023 Trust Disclosed balance after: 93,088 Read SEC document |
| May 13, 2025 Filed May 15, 2025 17:56 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 90,076 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-072916 · ownership.xml · nonDerivative · entry 1 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By 2022 GRAT Disclosed balance after: 0 Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 19:35 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 4,742 | $321.92 | $1,526,544.64 |
DisclosureSEC source: 0000950170-25-022662 · ownership.xml · nonDerivative · entry 2 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,676 Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 19:35 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 13,218 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-022662 · ownership.xml · nonDerivative · entry 1 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,418 F1 · kind: On January 28, 2022, the reporting person was granted 25,470 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2022-2024. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2022-2024 earnings per share, the number of performance share units that vested equaled 51.9% of the units granted. Read SEC document |
| January 28, 2025 Filed Jan 30, 2025 18:44 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 74,620 | $0.00 Strike: $328.70 | $0.00 |
DisclosureSEC source: 0000950170-25-011254 · ownership.xml · derivative · entry 1 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,620 Underlying: Common Stock · 74,620 shares Expires 2035-01-28 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 28, 2026. Read SEC document |
| August 08, 2024 Filed Aug 8, 2024 17:53 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 7,115 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-094233 · ownership.xml · nonDerivative · entry 8 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By HD Trust Disclosed balance after: 14,979 Read SEC document |
| August 08, 2024 Filed Aug 8, 2024 17:53 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 7,115 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-094233 · ownership.xml · nonDerivative · entry 7 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 0 Read SEC document |
| August 06, 2024 Filed Aug 8, 2024 17:53 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 3,012 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-094233 · ownership.xml · nonDerivative · entry 6 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By 2023 Trust Disclosed balance after: 3,012 Read SEC document |
| August 06, 2024 Filed Aug 8, 2024 17:53 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 3,012 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-094233 · ownership.xml · nonDerivative · entry 5 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,200 Read SEC document |
| August 06, 2024 Filed Aug 8, 2024 17:53 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 12,084 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-094233 · ownership.xml · nonDerivative · entry 4 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By 2023 GST Trust Disclosed balance after: 16,731 Read SEC document |
| August 06, 2024 Filed Aug 8, 2024 17:53 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 12,084 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-094233 · ownership.xml · nonDerivative · entry 3 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,212 Read SEC document |
| August 06, 2024 Filed Aug 8, 2024 17:53 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 7,115 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-094233 · ownership.xml · nonDerivative · entry 2 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 7,115 Read SEC document |
| August 06, 2024 Filed Aug 8, 2024 17:53 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 7,115 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-094233 · ownership.xml · nonDerivative · entry 1 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,296 Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 19:31 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 30,387 | $308.55 | $9,375,908.85 |
DisclosureSEC source: 0001209191-24-003747 · doc4.xml · nonDerivative · entry 2 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 265,744 Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 19:31 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 78,440 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-003747 · doc4.xml · nonDerivative · entry 1 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 296,131 F1 · kind: On February 3, 2021, the reporting person was granted 39,220 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2021-2023. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2021-2023 earnings per share, the number of performance share units that vested at 11:01 p.m. Central Time on February 16, 2024 equaled 200% of the units granted. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 18:43 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 79,784 | $0.00 Strike: $304.90 | $0.00 |
DisclosureSEC source: 0001209191-24-002724 · doc4.xml · derivative · entry 1 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,784 Underlying: Common Stock · 79,784 shares Expires 2034-01-31 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2025. Read SEC document |
| May 04, 2023 Filed May 8, 2023 17:19 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 4,647 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-028013 · doc4.xml · nonDerivative · entry 4 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By 2009 Trust Disclosed balance after: 4,647 Read SEC document |
| May 04, 2023 Filed May 8, 2023 17:19 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 4,647 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-028013 · doc4.xml · nonDerivative · entry 3 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,276 Read SEC document |
| May 04, 2023 Filed May 8, 2023 17:19 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 7,864 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-028013 · doc4.xml · nonDerivative · entry 2 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By HD Trust Disclosed balance after: 7,864 Read SEC document |
| May 04, 2023 Filed May 8, 2023 17:19 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 7,864 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-028013 · doc4.xml · nonDerivative · entry 1 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,923 Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 20:05 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 36,770 | $262.84 | $9,664,626.80 |
DisclosureSEC source: 0001209191-23-012000 · doc4.xml · nonDerivative · entry 2 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,787 Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 20:05 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 94,880 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-012000 · doc4.xml · nonDerivative · entry 1 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,557 F1 · kind: On January 29, 2020, the reporting person was granted 47,440 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2020-2022. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2020-2022 earnings per share, the number of performance share units that vested equaled 200% of the units granted. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 18:40 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 59,000 | $0.00 Strike: $68.96 | $0.00 |
DisclosureSEC source: 0001209191-23-007674 · doc4.xml · derivative · entry 5 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 59,000 shares Expires 2025-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 4, 2016. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 18:40 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 32,208 | $258.08 | $8,312,240.64 |
DisclosureSEC source: 0001209191-23-007674 · doc4.xml · nonDerivative · entry 2 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,677 Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 18:40 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 59,000 | $68.96 | $4,068,640.00 |
DisclosureSEC source: 0001209191-23-007674 · doc4.xml · nonDerivative · entry 1 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,885 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2023 Filed Feb 1, 2023 19:59 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 82,880 | $0.00 Strike: $253.30 | $0.00 |
DisclosureSEC source: 0001209191-23-006034 · doc4.xml · derivative · entry 1 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,880 Underlying: Common Stock · 82,880 shares Expires 2033-01-30 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 30, 2024. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:16 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionRestricted Stock Units · Derivative | 6,011 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-012408 · doc4.xml · derivative · entry 5 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,011 shares Expires 2022-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:16 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 35,830 | $244.10 | $8,746,103.00 |
DisclosureSEC source: 0001209191-22-012408 · doc4.xml · nonDerivative · entry 3 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 378,885 Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:16 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 6,011 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-012408 · doc4.xml · nonDerivative · entry 2 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 414,715 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:16 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 85,040 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-012408 · doc4.xml · nonDerivative · entry 1 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 408,704 F1 · kind: On January 30, 2019, the reporting person was granted 42,520 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2019-2021. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2019-2021 earnings per share, the number of performance share units that vested equaled 200% of the units granted. Read SEC document |
| January 28, 2022 Filed Feb 1, 2022 19:25 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 86,630 | $0.00 Strike: $236.61 | $0.00 |
DisclosureSEC source: 0001209191-22-006075 · doc4.xml · derivative · entry 1 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,630 Underlying: Common Stock · 86,630 shares Expires 2032-01-28 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 28, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.